Are jumping mechanography assessed muscle force and power, and traditional physical capability measures associated with falls in older adults? Results from the Hertfordshire Cohort Study.


Journal

Journal of musculoskeletal & neuronal interactions
ISSN: 1108-7161
Titre abrégé: J Musculoskelet Neuronal Interact
Pays: Greece
ID NLM: 101084496

Informations de publication

Date de publication:
01 06 2020
Historique:
entrez: 3 6 2020
pubmed: 3 6 2020
medline: 5 6 2021
Statut: ppublish

Résumé

To explore associations between measures of lower limb muscle force, velocity and power from jumping mechanography (JM) and simple physical capability (PC) testing, and falls in community dwelling older adults. Participants performed a two-leg countermovement jump on a ground reaction force platform. Jump force, power and velocity were calculated. PC tests were 6m timed-up-and-go (TUG)(sec), grip strength (kg), gait speed (m/s) and chair rise time (secs). Two-three years after JM and PC testing, self-reported falls in the previous year were recorded, and logistic regression analysis used to determine whether JM and PC measures were associated with falls. Fall and PC data were available for 258 (169 JM) participants. Mean (SD) age at baseline was 75(2.5) years, 50% (n=129) were women and 27% (n=70) had fallen. As power and velocity increased, the odds of being a faller decreased [(odds ratio (OR)=0.91, 95% confidence interval (CI) 0.85,0.98] and (OR=0.20, 95% CI 0.05 0.72) respectively). Whilst grip strength and TUG were associated with falling; relationships were attenuated after adjustment. Jumping mechanography-measured muscle power and velocity were associated with lower risk of falls. In this relatively healthy cohort of older adults JM appears to be more sensitive measure of muscle deficits and falls risk than standard PC measures.

Identifiants

pubmed: 32481232
pmc: PMC7288388

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

168-175

Subventions

Organisme : Medical Research Council
ID : MC_UP_A620_1015
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U147585827
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12011/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U147585819
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_A620_1014
Pays : United Kingdom
Organisme : Versus Arthritis
ID : 19583
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12011/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0400491
Pays : United Kingdom
Organisme : Medical Research Council
ID : U105960371
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U147585824
Pays : United Kingdom

Déclaration de conflit d'intérêts

Professor Cyrus Cooper has received lecture fees and honoraria from Amgen, Danone, Eli Lilly, GSK, Kyowa Kirin, Medtronic, Merck, Nestlé, Novartis, Pfizer, Roche, Servier, Shire, Takeda and UCB outside of the submitted work. Camille M Parsons, Mark H Edwards, Elaine M Dennison and Kate A Ward have nothing to disclose.

Références

J Nutr Health Aging. 2018;22(10):1167-1175
pubmed: 30498822
Age Ageing. 2002 Mar;31(2):119-25
pubmed: 11937474
Aging Clin Exp Res. 2019 Oct;31(10):1435-1442
pubmed: 30515724
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
Int J Epidemiol. 2005 Dec;34(6):1234-42
pubmed: 15964908
J Am Geriatr Soc. 2015 Feb;63(2):315-20
pubmed: 25688606
J Cachexia Sarcopenia Muscle. 2017 Aug;8(4):598-606
pubmed: 28474432
Osteoporos Int. 2019 Jan;30(1):211-220
pubmed: 30552442
J Gerontol A Biol Sci Med Sci. 1998 Mar;53(2):M112-9
pubmed: 9520917
J Musculoskelet Neuronal Interact. 2012 Jun;12(2):46-55
pubmed: 22647277
Clin Physiol Funct Imaging. 2004 Nov;24(6):335-40
pubmed: 15522042
Eur J Appl Physiol. 2001 Dec;86(2):169-73
pubmed: 11822476
Rejuvenation Res. 2014 Jun;17(3):276-84
pubmed: 24387140
Age Ageing. 2011 Jul;40(4):423-9
pubmed: 21624928
J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):920-928
pubmed: 30221478
Eur J Ageing. 2004 Dec;1(1):89-94
pubmed: 28794706
Clin Sci (Lond). 1992 Mar;82(3):321-7
pubmed: 1312417
J Clin Endocrinol Metab. 2014 Jan;99(1):266-75
pubmed: 24203064
J Musculoskelet Neuronal Interact. 2015 Sep;15(3):249-56
pubmed: 26350943
Med Sci Sports Exerc. 2009 Feb;41(2):418-25
pubmed: 19127182
Lancet. 2015 Jul 18;386(9990):266-73
pubmed: 25982160
J Musculoskelet Neuronal Interact. 2017 Sep 1;17(3):246-257
pubmed: 28860427

Auteurs

Camille M Parsons (CM)

MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK.

Mark H Edwards (MH)

MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK.
Portsmouth Hospitals NHS Trust, Portsmouth, UK.

Cyrus Cooper (C)

MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK.
National Institute for Health Research Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, UK.
National Institute for Health Research Musculoskeletal Biomedical Research Unit, University of Oxford, UK.

Elaine M Dennison (EM)

MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK.

Kate A Ward (KA)

MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK.
MRC Nutrition and Bone Health Research Group, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH